miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas

Table 1 The clinical, laboratory characteristics of paitents

Clinical and pathological features	n	miR-18a + high	miR-18a -low	P Value
Gender
Men	65	35	30
female	35	16	19	0.5304
Age
≥50	55	28	27
< 50	45	23	22	1.000
Extranodal lymph node metastasis
Yes	71	43	28
NO	29	8	21	0.0039
Clinical stage
I-II	37	12	25
III-IV	63	39	20	0.0017
EBV(EBNA-1)
+	51	42	9
–	49	9	40	< 0.0001

ISSN: 1471-2407